TY - JOUR
T1 - Pancreas transplantation
T2 - A single-institution experience in Japan
AU - Okabe, Yasuhiro
AU - Kitada, Hidehisa
AU - Miura, Yoshifumi
AU - Nishiki, Takehiro
AU - Kurihara, Kei
AU - Kawanami, Sayako
AU - Terasaka, Soshi
AU - Kaku, Keizo
AU - Noguchi, Hiroshi
AU - Sugitani, Atsushi
AU - Tanaka, Masao
N1 - Funding Information:
Masao Tanaka received research funding from Astellas and Novartis.
PY - 2013/12
Y1 - 2013/12
N2 - Purpose: We herein report our experience with pancreas transplantation in 26 patients at a single institution in Japan between August 2001 and December 2011. Methods: We reviewed the medical records of 26 pancreas transplantations performed in our institute. Results: The early complications (within 2 weeks) included one graft venous thrombosis, one arterial thrombosis, and two reoperations for bleeding. Of the 26 pancreas transplant recipients, five lost pancreas graft function. Of 24 simultaneous pancreas-kidney recipients, three lost kidney graft function due to noncompliance. The patient, pancreas, and kidney survival rates were 100, 96 and 93 % at 1 year; 100, 80 and 93 % at 5 years; and 100, 67 and 68 % at 10 years, respectively. Of all these complications, venous thrombosis after pancreas transplantation was the most critical. Conclusions: As the largest series of pancreas transplantations in a single institution in Japan, our series yielded better results than the worldwide data recorded by the International Pancreas Transplant Registry. Routine postoperative anticoagulation therapy is not necessary for the prevention of graft thrombosis if sufficient fluid infusion is strictly controlled and the graft blood flow is frequently monitored. When graft thrombosis occurs, both early detection and appropriate intervention are extremely important if the pancreas graft is to survive.
AB - Purpose: We herein report our experience with pancreas transplantation in 26 patients at a single institution in Japan between August 2001 and December 2011. Methods: We reviewed the medical records of 26 pancreas transplantations performed in our institute. Results: The early complications (within 2 weeks) included one graft venous thrombosis, one arterial thrombosis, and two reoperations for bleeding. Of the 26 pancreas transplant recipients, five lost pancreas graft function. Of 24 simultaneous pancreas-kidney recipients, three lost kidney graft function due to noncompliance. The patient, pancreas, and kidney survival rates were 100, 96 and 93 % at 1 year; 100, 80 and 93 % at 5 years; and 100, 67 and 68 % at 10 years, respectively. Of all these complications, venous thrombosis after pancreas transplantation was the most critical. Conclusions: As the largest series of pancreas transplantations in a single institution in Japan, our series yielded better results than the worldwide data recorded by the International Pancreas Transplant Registry. Routine postoperative anticoagulation therapy is not necessary for the prevention of graft thrombosis if sufficient fluid infusion is strictly controlled and the graft blood flow is frequently monitored. When graft thrombosis occurs, both early detection and appropriate intervention are extremely important if the pancreas graft is to survive.
UR - http://www.scopus.com/inward/record.url?scp=84892372179&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84892372179&partnerID=8YFLogxK
U2 - 10.1007/s00595-013-0516-6
DO - 10.1007/s00595-013-0516-6
M3 - Article
C2 - 23423217
AN - SCOPUS:84892372179
SN - 0941-1291
VL - 43
SP - 1406
EP - 1411
JO - Surgery Today
JF - Surgery Today
IS - 12
ER -